ONTOLOGY SOURCE REFERENCE
Term Source Name	"OBI"	"BTO"	"NCBITaxon"	"UO"	"CHEBI"	
Term Source File	""	"http://bioportal.bioontology.org/ontologies/47507"	"http://bioportal.bioontology.org/ontologies/38802"	"http://bioportal.bioontology.org/ontologies/47686"	"http://bioportal.bioontology.org/ontologies/46957"	
Term Source Version	""	"47507"	"38802"	"47686"	"46957"	
Term Source Description	"Ontology for Biomedical Investigations"	"BRENDA tissue / enzyme source"	"NCBI organismal classification"	"Units of measurement"	"Chemical entities of biological interest"	
INVESTIGATION
Investigation Identifier	"Inv_001"
Investigation Title	"Investigation"
Investigation Description	""
Investigation Submission Date	""
Investigation Public Release Date	""
Comment [Created with configuration]	""
Comment [Last Opened With Configuration]	""
INVESTIGATION PUBLICATIONS
Investigation PubMed ID		
Investigation Publication DOI		
Investigation Publication Author List		
Investigation Publication Title		
Investigation Publication Status		
Investigation Publication Status Term Accession Number		
Investigation Publication Status Term Source REF		
INVESTIGATION CONTACTS
Investigation Person Last Name		
Investigation Person First Name		
Investigation Person Mid Initials		
Investigation Person Email		
Investigation Person Phone		
Investigation Person Fax		
Investigation Person Address		
Investigation Person Affiliation		
Investigation Person Roles		
Investigation Person Roles Term Accession Number		
Investigation Person Roles Term Source REF		
STUDY
Study Identifier	"T3"
Study Title	"T3-2x3x3-compound-dose-time"
Study Description	"a study evaluating the effect of 2 non steroidian anti inflammatory drugs administered in a single time, at 3 doses and with samples collected at 3 differents times following exposure"
Study Submission Date	"2013-01-21"
Study Public Release Date	"2013-01-21"
Study File Name	"s_T3.txt"
STUDY DESIGN DESCRIPTORS
Study Design Type	OBI:parallel group design	OBI:intervention design	OBI:dose response design	OBI:factorial design	
Study Design Type Term Accession Number					
Study Design Type Term Source REF					
STUDY PUBLICATIONS
Study PubMed ID	21360558	
Study Publication DOI	10.1002/jat.1638	
Study Publication Author List	Ch‡vez E, Castro-S‡nchez L, Shibayama M, Tsutsumi V, PŽrez Salazar E, Moreno MG, Muriel P.	
Study Publication Title	Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4.	
Study Publication Status	Published	
Study Publication Status Term Accession Number		
Study Publication Status Term Source REF		
STUDY FACTORS
Study Factor Name	compound	dose	time	
Study Factor Type	chemical compound(http://purl.obolibrary.org/obo/CHEBI_37577)	dose(http://purl.obolibrary.org/obo/OBI_0000984)	time(http://purl.obolibrary.org/obo/PATO_0000165)	
Study Factor Type Term Accession Number				
Study Factor Type Term Source REF				
STUDY ASSAYS
Study Assay File Name	a_T3-A1.txt	a_T3-A2.txt
Study Assay Measurement Type	transcription profiling	metabolite profiling
Study Assay Measurement Type Term Accession Number	0000424	0000366
Study Assay Measurement Type Term Source REF	OBI	OBI
Study Assay Technology Type	nucleotide sequencing	NMR spectroscopy
Study Assay Technology Type Term Accession Number		
Study Assay Technology Type Term Source REF	OBI	OBI
Study Assay Technology Platform		
STUDY PROTOCOLS
Study Protocol Name	nucleic acid extraction	library construction	nucleic acid sequencing	sequence analysis data transformation	extraction	labeling	NMR spectroscopy	nmr assay	data normalization	data transformation	sample collection	
Study Protocol Type	nucleic acid extraction	library construction	nucleic acid sequencing	sequence analysis data transformation	extraction	labeling	NMR spectroscopy	nmr assay	data normalization	data transformation	sample collection	
Study Protocol Type Term Accession Number												
Study Protocol Type Term Source REF												
Study Protocol Description												
Study Protocol URI												
Study Protocol Version												
Study Protocol Parameters Name		library layout;mid;	sequencing instrument;base caller;quality score;				instrument;NMR Probe;number of acquisition;magnetic field strength;					
Study Protocol Parameters Name Term Accession Number												
Study Protocol Parameters Name Term Source REF												
Study Protocol Components Name												
Study Protocol Components Type												
Study Protocol Components Type Term Accession Number												
Study Protocol Components Type Term Source REF												
STUDY CONTACTS
Study Person Last Name	Smith	
Study Person First Name	John	
Study Person Mid Initials	P	
Study Person Email	jps@wkri.org	
Study Person Phone		
Study Person Fax		
Study Person Address	1024 research drive, research state, science land	
Study Person Affiliation	Well Known Research Institute	
Study Person Roles	OBI:investigation agent role	
Study Person Roles Term Accession Number		
Study Person Roles Term Source REF		
